| http://www.w3.org/ns/prov#value | - Granulates comprising amoxicillin/clavulanate have been previously described in WO 98/35672 (SmithKline Beecham Laboratoires Pharmaceutique). [0090] Preferably, formulations of this invention comprise amoxicillin trihydrate and potassium clavulanate, this combination having met with regulatory approval, and being particularly advantageous. [0091] The pharmaceutical formulations of the present inve
|
